SEC Form 4 · accession 0001209191-17-041966
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tao Fu
Officer — EVP, CBO
Period of report
Jun 23, 2017
Accepted (ET)
Jun 27, 2017 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 23, 2017 | M | 2,604 | $25.54 | A | 2,604 | D | |
| Common StockF1 | Jun 23, 2017 | M | 1,396 | $33.49 | A | 1,396 | D | |
| Common StockF1 | Jun 23, 2017 | S | 4,000 | $55.00 | D | 0 | D | |
| Common StockF1 | Jun 26, 2017 | M | 3,000 | $33.49 | A | 3,000 | D | |
| Common StockF1 | Jun 26, 2017 | S | 3,000 | $60.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $25.54 | Jun 23, 2017 | M | 2,604 | D | Jan 30, 2017 | Jan 30, 2027 | Common Stock | 2,604 | 3,906 | D |
| Stock Option (Right to Buy)F1 | $33.49 | Jun 23, 2017 | M | 1,396 | D | Jan 27, 2016 | Jan 27, 2026 | Common Stock | 1,396 | 10,999 | D |
| Stock Option (Right to Buy)F1 | $33.49 | Jun 26, 2017 | M | 3,000 | D | Jan 27, 2016 | Jan 27, 2026 | Common Stock | 3,000 | 7,999 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.